Positioning of positively charged residues in the V3 loop correlates with HIV type 1 syncytium-inducing phenotype

被引:33
|
作者
Bhattacharyya, D
Brooks, BR
Callahan, L
机构
[1] NIH, DIV COMP RES & TECHNOL, STRUCT BIOL LAB, BETHESDA, MD 20892 USA
[2] US PHARMACOPEIAL CONVENT INC, ROCKVILLE, MD 20852 USA
关键词
HUMAN-IMMUNODEFICIENCY-VIRUS; PRINCIPAL NEUTRALIZING DETERMINANT; HEPARAN-SULFATE PROTEOGLYCANS; BIOLOGICAL PHENOTYPE; DEXTRAN SULFATE; INFECTION; DOMAIN; GP120; PROGRESSION; CAPACITY;
D O I
10.1089/aid.1996.12.83
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Although the V3 loop of the envelope glycoprotein (gp120) plays a role in determining the phenotype, pathogenesis, and tropism of human immunodeficiency virus-1 (HIV-1), there has not been any consistent correlation between structure and phenotype, Theoretically determined structures of the V3 loop of gp120, from 20 different viral strains, 10 syncytium-inducing (SI) and 10 non-syncytium-inducing (NSI) phenotype, revealed that all V3 loops from SI phenotypic strains had at least two positively charged residues in close proximity, on the same face of the loop, All of the SI phenotypic V3 loop structures were capable of forming strong divalent electrostatic interactions with disulfated sugars. The ability to form this interaction may be a determinant of the phenotype, tropism, and pathogenicity of HIV-1 viral strains, This structural motif was absent in all V3 loops from viral strains with the NSI phenotype.
引用
收藏
页码:83 / 90
页数:8
相关论文
共 50 条
  • [21] Diversity of HIV type 1 envelope V3 loop region in saliva
    Kakizawa, J
    Ushijima, H
    Morishita, Y
    Oka, S
    Ikeda, Y
    Muller, WEG
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1996, 12 (06) : 561 - 563
  • [22] Structural basis for coreceptor selectivity by the HIV type 1 V3 loop
    Cardozo, Timothy
    Kimura, Tetsuya
    Philpott, Sean
    Weiser, Barbara
    Burger, Harold
    Zolla-Pazner, Susan
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2007, 23 (03) : 415 - 426
  • [23] CCRS/△ccr5 heterozygosity:: A selective pressure for the syncytium-inducing human immunodeficiency virus type 1 phenotype
    D'Aquila, RT
    Sutton, L
    Savara, A
    Hughes, MD
    Johnson, VA
    JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (06): : 1549 - 1553
  • [24] Polymorphism in the interleukin-4 promoter affects acquisition of human immunodeficiency virus type 1 syncytium-inducing phenotype
    Nakayama, EE
    Hoshino, Y
    Xin, XM
    Liu, HL
    Goto, M
    Watanabe, N
    Taguchi, H
    Hitani, A
    Kawana-Tachikawa, A
    Fukushima, M
    Yamada, K
    Sugiura, W
    Oka, S
    Ajisawa, A
    Sato, H
    Takebe, Y
    Nakamura, T
    Nagai, Y
    Iwamoto, A
    Shioda, T
    JOURNAL OF VIROLOGY, 2000, 74 (12) : 5452 - 5459
  • [25] Association of syncytium-inducing phenotype of HIV-1 with CD4 cell count, viral load and sociodemographic characteristics
    Furrer, H
    Wendland, T
    Minder, C
    Christen, A
    von Overbeck, J
    Grunow, R
    Pichler, W
    Malinverni, RP
    AIDS, 1998, 12 (11) : 1341 - 1346
  • [26] PROGNOSTIC VALUE OF HIV-1 SYNCYTIUM-INDUCING PHENOTYPE FOR RATE OF CD4+ CELL DEPLETION AND PROGRESSION TO AIDS
    KOOT, M
    KEET, IPM
    VOS, AHV
    DEGOEDE, REY
    ROOS, MTL
    COUTINHO, RA
    MIEDEMA, F
    SCHELLEKENS, PTA
    TERSMETTE, M
    ANNALS OF INTERNAL MEDICINE, 1993, 118 (09) : 681 - 688
  • [27] Envelope diversity, coreceptor usage and syncytium-inducing phenotype of HIV-1 variants in saliva and blood during primary infection
    Freel, SA
    Fiscus, SA
    Pilcher, CD
    Menezes, P
    Giner, J
    Patrick, E
    Lennox, JL
    Hicks, CB
    Eron, JJ
    Shugars, DC
    AIDS, 2003, 17 (14) : 2025 - 2033
  • [28] Lower prevalence and incidence of HIV-1 syncytium-inducing phenotype among injecting drug users relative to homosexual men
    Mocroft, A
    Sabin, CA
    Phillips, AN
    AIDS, 1996, 10 (03) : 344 - 345
  • [29] Prevalence and incidence of HIV-1 syncytium-inducing phenotype among injecting drug users in south-eastern Italy
    Angarano, G
    Monno, L
    Fiore, JR
    Fracasso, C
    LaGrasta, L
    Romanelli, C
    AIDS, 1996, 10 (07) : 805 - 806
  • [30] INSERTION OF PRIMARY SYNCYTIUM-INDUCING (SI) AND NON-SI ENVELOPE V3 LOOPS IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) LAI REDUCES NEUTRALIZATION SENSITIVITY TO AUTOLOGOUS, BUT NOT HETEROLOGOUS, HIV-1 ANTIBODIES
    HOGERVORST, E
    DEJONG, J
    VANWIJK, A
    BAKKER, M
    VALK, M
    NARA, P
    GOUDSMIT, J
    JOURNAL OF VIROLOGY, 1995, 69 (10) : 6342 - 6351